Literature DB >> 7738151

Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories.

A M Vandamme1, K Fransen, L Debaisieux, D Marissens, S Sprecher, D Vaira, A T Vandenbroucke, C Verhofstede.   

Abstract

Eight Belgian AIDS Reference Laboratories established a multicentre quality control to evaluate the performance of their diagnostic human immunodeficiency virus type 1 (HIV-1) DNA polymerase chain reaction (PCR). A set of Belgian and African HIV-1 seropositive and seronegative patient samples, collected in Belgium, and the British Medical Research Council (MRC) HIV-1 PCR reference reagent kit, containing plasmid HIV-1 DNA at several dilutions in human carrier DNA with appropriate negative controls, were tested by the laboratories. No false positive results were reported. All laboratories were able to detect one to two copies of HIV-1 DNA. Among the 17 Belgian and African HIV-1 seropositives, some laboratories reported up to four indeterminate results, mainly due to failure of the SK38-39, SK68-69 (Ou et al. (1988) Science 239, 295-297) and/or gag881-882 (Simmonds et al. (1990) J. Virol. 64, 864-872) primers and a poorly performing algorithm. Only the H1POL4235-4538 nested pol primer set, developed by one of the laboratories, correctly identified all the tested HIV-1 positive and negative samples. Consequently, the laboratories decided to evaluate these pol primers as a reference primer set and to standardise the testing algorithm. All laboratories achieved a sensitivity and specificity of 100% on testing 10 additional Belgian and African patient samples, when adapting a standardised algorithm based on three HIV-1 primer sets, one of which is the H1POL4235-4538 primer set.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738151     DOI: 10.1016/0166-0934(94)00126-2

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  17 in total

1.  Multicenter quality assessment of PCR methods for detection of enteroviruses.

Authors:  P Muir; A Ras; P E Klapper; G M Cleator; K Korn; C Aepinus; A Fomsgaard; P Palmer; A Samuelsson; A Tenorio; B Weissbrich; A M van Loon
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Viral load, CD4+ T-lymphocyte counts and antibody titres in HIV-1 infected untreated children in Kenya; implication for immunodeficiency and AIDS progression.

Authors:  Washingtone Ochieng; Dorington Ogoyi; Francis J Mulaa; Simon Ogola; Rachel Musoke; Moses G Otsyula
Journal:  Afr Health Sci       Date:  2006-03       Impact factor: 0.927

3.  African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.

Authors:  A M Vandamme; M Salemi; M Van Brussel; H F Liu; K Van Laethem; M Van Ranst; L Michels; J Desmyter; P Goubau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 4.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Dilution assessment of cervicovaginal secretions collected by vaginal washing to evaluate mucosal shedding of free human immunodeficiency virus.

Authors:  A S Mohamed; P Becquart; H Hocini; P Métais; M Kazatchkine; L Bélec
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

6.  Sequence and drug susceptibility of subtype C reverse transcriptase from human immunodeficiency virus type 1 seroconverters in Zimbabwe.

Authors:  R W Shafer; J A Eisen; T C Merigan; D A Katzenstein
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness.

Authors:  V Lejon; D Mumba Ngoyi; M Ilunga; G Beelaert; I Maes; P Büscher; K Fransen
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

8.  Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults.

Authors:  E Lyamuya; U Bredberg-Rådén; J Albert; O Grankvist; V Msangi; C Kagoma; F Mhalu; G Biberfeld
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

9.  SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus.

Authors:  M Witvrouw; J Balzarini; C Pannecouque; S Jhaumeer-Laulloo; J A Esté; D Schols; P Cherepanov; J C Schmit; Z Debyser; A M Vandamme; J Desmyter; S R Ramadas; E de Clercq
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

10.  Uptake of amplifiable fragments of retrotransposon DNA from the human alimentary tract.

Authors:  A Forsman; D Ushameckis; A Bindra; Z Yun; J Blomberg
Journal:  Mol Genet Genomics       Date:  2003-10-11       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.